Information for "Pseudotyping associated with VSV together with Ebola virus glycoprotein is superior to HIV1 for the review associated with neutralising antibodies"
From EECH Central
Basic information
| Display title | Pseudotyping associated with VSV together with Ebola virus glycoprotein is superior to HIV1 for the review associated with neutralising antibodies |
| Default sort key | Pseudotyping associated with VSV together with Ebola virus glycoprotein is superior to HIV1 for the review associated with neutralising antibodies |
| Page length (in bytes) | 3,172 |
| Page ID | 1381464 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Kendotailor82 (Talk | contribs) |
| Date of page creation | 09:03, 19 April 2024 |
| Latest editor | Kendotailor82 (Talk | contribs) |
| Date of latest edit | 09:03, 19 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
